Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Champions Oncology (CSBR) Asset Utilization Ratio (2016 - 2026)

Champions Oncology has reported Asset Utilization Ratio over the past 16 years, most recently at 1.98 for Q1 2026.

  • For Q1 2026, Asset Utilization Ratio fell 5.73% year-over-year to 1.98; the TTM value through Jan 2026 reached 1.98, down 5.73%, while the annual FY2025 figure was 1.95, 17.36% up from the prior year.
  • Asset Utilization Ratio for Q1 2026 was 1.98 at Champions Oncology, up from 1.92 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 2.14 in Q4 2024 and troughed at 1.42 in Q2 2022.
  • A 5-year average of 1.75 and a median of 1.79 in 2024 define the central range for Asset Utilization Ratio.
  • Biggest five-year swings in Asset Utilization Ratio: rose 24.34% in 2024 and later dropped 10.59% in 2025.
  • Year by year, Asset Utilization Ratio stood at 1.53 in 2022, then rose by 12.32% to 1.72 in 2023, then increased by 24.34% to 2.14 in 2024, then dropped by 9.87% to 1.92 in 2025, then increased by 2.73% to 1.98 in 2026.
  • Business Quant data shows Asset Utilization Ratio for CSBR at 1.98 in Q1 2026, 1.92 in Q4 2025, and 1.81 in Q3 2025.